Silence Therapeutics plc (LON:SLN)’s share price hit a new 52-week high on Wednesday . The stock traded as high as GBX 215.25 ($2.83) and last traded at GBX 206 ($2.71), with a volume of 135,821 shares. The stock had previously closed at GBX 204 ($2.68).
In other news, insider Andy Richards bought 7,000 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were purchased at an average price of GBX 147 ($1.93) per share, for a total transaction of £10,290 ($13,528.79). Also, insider Alistair Gray bought 3,848 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The stock was purchased at an average price of GBX 130 ($1.71) per share, for a total transaction of £5,002.40 ($6,576.91).
About Silence Therapeutics plc
Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company’s technology harnesses the body’s natural mechanisms to create therapeutic effects within its own cells.
Receive News & Ratings for Silence Therapeutics plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics plc and related companies with MarketBeat.com's FREE daily email newsletter.